NCT02368275

Brief Summary

The objective of these cohorts is to detect potential genetic, neurophysiological psychological and cognitive risk factors for the development of chronic postsurgical pain including neuropathic pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2017

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 23, 2015

Completed
2 years until next milestone

Study Start

First participant enrolled

March 1, 2017

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2020

Completed
Last Updated

April 30, 2021

Status Verified

April 1, 2021

Enrollment Period

3.4 years

First QC Date

February 13, 2015

Last Update Submit

April 29, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • neuropathic pain

    neuropathic pain assessed with the DN4 questionnaire

    3, 6 and 12 months after surgery in the prospective cohort

Secondary Outcomes (1)

  • chronic postsurgical pain

    3, 6 and 12 months after surgery

Study Arms (2)

prospective cohort of patients undergoing mastectomy

Prospective cohort

cross sectional cohort of patients

Cross sectional cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The first group of patients consists of women recruited from René Huguenin Hospital (Saint Cloud, Ile de France) for mastectomy or lumpectomy to treat breast cancer, with axillary lymph node dissection in all cases. The second cohort will consist of women already operared of breast surgery in the last 2 years. The third cohort will consist of men or women recruited from Foch hospital (Suresnes, Ile de France) for thoracotomy for cancer.

You may qualify if:

  • Patients undergoing surgery for breast cancer or thoracotomy for lung cancer followed during the course of the study or patients from the French cohort Seintinelle already operated from breast surgery over the past 2 years.

You may not qualify if:

  • Patients are not included if they have clinically significant or unstable psychiatric or somatic conditions (e.g. major depression, psychosis, uncontrolled diabetes mellitus or hypertension, neurological disorders, immune disease, body mass index \> 45), past or present substance abuse or any cognitive deterioration based on past medical history, semi-structured interview and lack of completion or full understanding of questionnaires.
  • Bilateral mastectomy (for women undergoing breast surgery)
  • Presence of pain before surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hôpital Foch

Suresnes, Hauts De Seine, 92, France

Location

Hôpital Ambroise Paré

Boulogne-Billancourt, 92100, France

Location

Related Publications (1)

  • Sperandio G, Baudic S, Bennedsgaard K, Grosen K, Andersen IS, Finnerup NB, Albi-Feldzer A, Flor H, Nees F, Bouhassira D, Attal N. Somatic and psychological predictors of chronic postsurgical pain in cancer patients: a machine learning approach in a longitudinal two-centre study. Br J Anaesth. 2026 Jan 7:S0007-0912(25)00847-5. doi: 10.1016/j.bja.2025.12.002. Online ahead of print.

Biospecimen

Retention: SAMPLES WITH DNA

The samples will use GWAS to detect potential genetic risk factors for neuropathic pain. These data will be analysed in Oxford laboratory (McCarthy).

Study Officials

  • Nadine ATTAL, MD, PhD

    Principal Investigator

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 13, 2015

First Posted

February 23, 2015

Study Start

March 1, 2017

Primary Completion

July 30, 2020

Study Completion

September 30, 2020

Last Updated

April 30, 2021

Record last verified: 2021-04

Locations